Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls
Ahn Y, Lee K, Kim C, Kim J, Kang D, Jun T, Choi J, Chung I, Kim H, Hwang S, Kim Y. Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls. Journal Of Clinical Psychopharmacology 2009, 29: 117-123. PMID: 19512972, DOI: 10.1097/jcp.0b013e31819a6995.Peer-Reviewed Original ResearchConceptsNormal controlsNeurocognitive functionPP analysisControl groupSecond-generation antipsychoticsEffect sizeHealthy control groupNeurocognitive function testsLong-term improvementComposite effect sizeFunction testsPatient groupMedication effectsTrail Making TestPatientsCognitive improvementPractice effectsSchizophreniaTest batteryRelative effect sizesITTMost measuresGroupAntipsychoticsAmisulpride